Get started
ORBUSN.MED.GRP.HL.DL-,001ORBUSN.MED.GRP.HL.DL-,001ORBUSN.MED.GRP.HL.DL-,001

ORBUSN.MED.GRP.HL.DL-,001

No trades
See on Supercharts
Overview
Financials News Discussions Forecast Seasonals

Q8T chart


Full chart

Q8T upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪330.11 M‬ EUR
Dividend yield (indicated)
2.79%
Price to earnings Ratio (TTM)
8.408
Basic EPS (TTM)
0.046 EUR
Net income (FY)
‪38.52 M‬ EUR
Revenue (FY)
‪159.16 M‬ EUR
Shares float
‪823.51 M‬
Beta (1Y)
0.83

Employees


Employees (FY)
‪1.33 K‬
Change (1Y)
+82 +6.57%
Revenue / Employee (1Y)
—
Net income / Employee (1Y)
—

About ORBUSNEICH MEDICAL GRP HLDGS LTD


Sector
Health Technology
Industry
Medical Specialties
CEO
David Chien
Headquarters
Hong Kong
FIGI
BBG01GN9DZ79
OrbusNeich Medical Group Holdings Ltd. operates as an investment holding company. The firm through its subsidiaries engages in the manufacturing, trading, sales and marketing of medical devices & instruments used for the treatment of coronary and peripheral vascular diseases. The company was founded on July 22, 2021 and is headquartered in Hong Kong.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

Q8T news



Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as Q8T.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ORBUSN.MED.GRP.HL.DL-,001 stocks are traded under the ticker Q8T.
We've gathered analysts' opinions on ORBUSN.MED.GRP.HL.DL-,001 future price: according to them, Q8T price has a max estimate of 0.76 EUR and a min estimate of 0.56 EUR. Watch Q8T chart and read a more detailed ORBUSN.MED.GRP.HL.DL-,001 stock forecast: see what analysts think of ORBUSN.MED.GRP.HL.DL-,001 and suggest that you do with its stocks.
Q8T reached its all-time high on May 17, 2023 with the price of 1.588 EUR, and its all-time low was 0.282 EUR and was reached on Aug 5, 2024. View more price dynamics on Q8T chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track ORBUSN.MED.GRP.HL.DL-,001 financials in yearly and quarterly reports right on TradingView.
ORBUSN.MED.GRP.HL.DL-,001 is going to release the next earnings report on Aug 15, 2025. Keep track of upcoming events with our Earnings Calendar.
Q8T net income for the last half-year is ‪20.22 M‬ EUR, while the previous report showed ‪17.60 M‬ EUR of net income which accounts for 14.91% change. Track more ORBUSN.MED.GRP.HL.DL-,001 financial stats to get the full picture.
ORBUSN.MED.GRP.HL.DL-,001 dividend yield was 2.67% in 2024, and payout ratio reached 26.65%. The year before the numbers were 1.42% and 23.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 5, 2025, the company has ‪1.33 K‬ employees. See our rating of the largest employees — is ORBUSN.MED.GRP.HL.DL-,001 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORBUSN.MED.GRP.HL.DL-,001 EBITDA is ‪38.83 M‬ EUR, and current EBITDA margin is 24.18%. See more stats in ORBUSN.MED.GRP.HL.DL-,001 financial statements.
Like other stocks, Q8T shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORBUSN.MED.GRP.HL.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.